UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D. C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act Of 1934
July
14, 2005
Date
of
Report (Date of earliest event reported)
ACURA
PHARMACEUTICALS, INC.
(Exact
Name of Registrant as Specified in Charter)
State
of New York
|
1-10113
|
11-0853640
|
(State
of Other Jurisdiction
|
(Commission
File Number)
|
(I.R.S.
Employer
|
of
Incorporation)
|
|
|
616
N. North Court, Suite 120
Palatine,
Illinois 60067
(Address
of principal executive offices) (Zip Code)
(847)
705-7709
(Registrant’s
telephone number, including are code)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
› |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
› |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17CFR
240.14a-12)
|
› |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17CFR240.14d-2(b))
|
› |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17CFR
240.13e- 4(c))
|
Item
2.02 Results
of Operations and Financial Condition
On
July
14, 2005, Acura Pharmaceuticals, Inc. (the "Company") issued a press release
disclosing the financial results for its second quarter ended June 30, 2005.
A
copy of the Company's press release is attached as Exhibit 99.1
hereto.
Item
9.01 Financial
Statements and Exhibits.
Exhibit
Number
|
Description |
99.1 |
Press
Release dated July 14, 2005 Announcing Results for Second
Quarter ended June 30, 2005.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
|
|
|
ACURA
PHARMACEUTICALS, INC. |
|
|
|
Date:
July
14, 2005 |
By: |
/s/ Peter
A. Clemens |
|
Peter
A. Clemens |
|
Vice
President & Chief Financial
Officer |
EXHIBIT
INDEX
Exhibit
Number
|
Description |
99.1 |
Press
Release dated July 14, 2005 Announcing Results for Second
Quarter ended June 30, 2005.
|